drug

The COPUS intervention

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Rigshospitalet, Denmark
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis
NCT03409393—Completed

KOLs & investigators

2
Julie A Kreyenbuhl, Pharm.D PhDKOL score 5
Helle Schnor, Ph.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Rigshospitalet, Denmark
company
trial
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis
NA
trial
indication
Schizophrenia
indication
Schizotypal Disorder
indication
First Episode Psychosis
indication
Schizotypal Personality Disorder
indication
KOL
Julie A Kreyenbuhl, Pharm.D PhD
KOL score 5
person
Helle Schnor, Ph.D.
KOL score —
person